DRUG

tACS

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for tACS

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
CD44 poor prognosis 0.230 Mid partial evidence none

Clinical trials

200 registered trials for tACS

Source: ClinicalTrials.gov